Investor Presentaiton

COVID-19 VACCINE 1813 COVID-19 VACCINE COVID-19 VACCINE COVID-19 VACCINE 21 COVID-19 VACCINE COVID-19 VACCINE 187 COVID-19 VACCINE COVID-19 VACCINE COVID-19 VACCINE K COVID-19 COVID-19 K COVID-19 VACCINE JACCINE COVID-19 22:13 COVID-19 VACCINE COVID-19 VACCINE 321 BR COVID-19 VACCINE COVID-19 VACCINE COVID-19 VACCINE 3327 The 20th century has seen the emergence of the life science industry, with growth accelerating in the 1970-80s. China's life science industry has been catching up with significant progress in the last decade. The COVID-19 pandemic, new vaccine advances as well as development of medical technology I have made the life science sector a key focus for investment. The 14th Five-Year Plan on Health launched in May 2022 is set to upgrade the healthcare system and speed up the informatisation of the sector. By 2035, the Chinese average life expectancy is expected to reach over 80. The life sciences sector has been developing and innovating over the decades, though it only came under the spotlight recently. Faced with broad demands from companies and the promising future of the industry, real estate investors are increasingly showing interest. According to Pitch Book, the US still dominates financing of the life sciences sector, accounting for 67% of the global investment (including M&A, IPO, PE/VC), but over the past five years, China has seen its market share increase by 3-5 percentage points (ppts). In China, a shortage of R&D facilities and rapidly growing demand will keep vacancy rates low and push rents to new highs, attracting new investment and compressing yields. This report aims to provide a basic understanding of the Chinese life sciences market, including industry growth drivers, market dynamics and most importantly, the real estate needs, trends and outlook. We've selected two large life science companies as the benchmark to figure out site selection strategies. We hope to provide a reference for landlords, end users, investors, governmental departments, operators and other industry participants. Foreword China Life Sciences - 2022

View entire presentation